Cargando…

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease

BACKGROUND: Parkinson's disease is characterized by a progressive loss of dopaminergic neurons in the substantia nigra. The cause of the neurodegeneration is unknown. Neuroinflammation has been clearly shown in Parkinson's disease and may be involved in the progressive nature of the diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pabon, Mibel M, Bachstetter, Adam D, Hudson, Charles E, Gemma, Carmelina, Bickford, Paula C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039584/ https://www.ncbi.nlm.nih.gov/pubmed/21266082 http://dx.doi.org/10.1186/1742-2094-8-9

Ejemplares similares

Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain
por: Bachstetter, Adam D, et al.
Publicado: (2008)

A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease
por: Pabon, Mibel M., et al.
Publicado: (2012)

Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
por: Yang, Jia-Le, et al.
Publicado: (2012)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
por: Limatola, Cristina, et al.
Publicado: (2014)

Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
por: Winter, Aimee N., et al.
Publicado: (2020)

The role of microglia in adult hippocampal neurogenesis
por: Gemma, Carmelina, et al.
Publicado: (2013)

CX(3)CR1-CX(3)CL1-dependent cell-to-cell Japanese encephalitis virus transmission by human microglial cells
por: Lannes, Nils, et al.
Publicado: (2019)

Microglial CX(3)CR1 promotes adult neurogenesis by inhibiting Sirt 1/p65 signaling independent of CX(3)CL1
por: Sellner, Sabine, et al.
Publicado: (2016)

Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1‐CX3CR1 signaling in a mouse model of retinitis pigmentosa
por: Zabel, Matthew K., et al.
Publicado: (2016)

Neuronal autophagy aggravates microglial inflammatory injury by downregulating CX3CL1/fractalkine after ischemic stroke
por: He, Hong-Yun, et al.
Publicado: (2019)

Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
por: Zhang, Jingjing, et al.
Publicado: (2018)

Polyphenol Supplementation Reverses Age-Related Changes in Microglial Signaling Cascades
por: Jalloh, Ahmad, et al.
Publicado: (2021)

Maternal Immune Activation Sensitizes Male Offspring Rats to Lipopolysaccharide-Induced Microglial Deficits Involving the Dysfunction of CD200–CD200R and CX3CL1–CX3CR1 Systems
por: Chamera, Katarzyna, et al.
Publicado: (2020)

Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury
por: Febinger, Heidi Y., et al.
Publicado: (2015)

PYNOD reduces microglial inflammation and consequent neurotoxicity upon lipopolysaccharides stimulation
por: Zeng, Qi, et al.
Publicado: (2018)

Exploration of C-terminal CX3CL1 for reducing age-dependent neurodegeneration
por: Hudobenko, Jacob, et al.
Publicado: (2023)

T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
por: Subbarayan, Meena S., et al.
Publicado: (2020)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
por: Pawelec, Paulina, et al.
Publicado: (2020)

Microglial Cx3cr1 knockout reduces prion disease incubation time in mice
por: Grizenkova, Julia, et al.
Publicado: (2014)

Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)

Spirulina Promotes Stem Cell Genesis and Protects against LPS Induced Declines in Neural Stem Cell Proliferation
por: Bachstetter, Adam D., et al.
Publicado: (2010)

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection
por: Chen, Peiqing, et al.
Publicado: (2016)

Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

Inhibitors of Microglial Neurotoxicity: Focus on Natural Products
por: Choi, Dong Kug, et al.
Publicado: (2011)

The brain’s best friend: microglial neurotoxicity revisited
por: Hellwig, Sabine, et al.
Publicado: (2013)

CX3CL1 intracellular domain and adult neurogenesis
por: Benoit, Marc R., et al.
Publicado: (2019)

MicroRNA-195 prevents hippocampal microglial/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1/CX3CR1 signaling
por: Mao, Meng, et al.
Publicado: (2020)

Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
por: Bian, Chao, et al.
Publicado: (2015)

Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
por: von Vietinghoff, Sibylle, et al.
Publicado: (2021)

Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation
por: Zhang, Yikui, et al.
Publicado: (2018)

Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes
por: Parillaud, Vincent R., et al.
Publicado: (2017)

Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
por: Zhang, Huili, et al.
Publicado: (2012)

CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
por: Zhuang, Quan, et al.
Publicado: (2017)

CX3CL1–CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis
por: Fernández-Prieto, Marta, et al.
Publicado: (2019)

CX(3)CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity
por: Sheridan, Graham K., et al.
Publicado: (2014)

Paeonol attenuates inflammation-mediated neurotoxicity and microglial activation
por: Nam, Kyong Nyon, et al.
Publicado: (2013)

Microglial Activation in Metal Neurotoxicity: Impact in Neurodegenerative Diseases
por: Martínez-Hernández, María I., et al.
Publicado: (2023)

Defective microglial development in the hippocampus of Cx3cr1 deficient mice
por: Pagani, Francesca, et al.
Publicado: (2015)

Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation: Targeting CX3CL1 to treat heart diseases
por: Zou, Lin, et al.
Publicado: (2023)

Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients
por: Cimato, Thomas R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g3km2t5bpsebce1qje97l98n8p